Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
MGTX
FDA Grants RMAT Designation to MeiraGTx's AAV2-hAQP1
| 2024-12-09 |
BIOTECHNOLOGY
MeiraGTx Receives FDA Designations
| 2024-11-13 |
BIOTECHNOLOGY
MeiraGTx Reports $84M Operating Loss
| 2024-03-15 |
BIOTECHNOLOGY
